| 000 | 00000nam##2200000za#4500 |
| 001 | 9.700029 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210625000641 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 150407|2014||||xxc|||||o f|0| 0 eng|d |
|---|
| 020 | |a978-1-100-25191-2 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP40-1/10-1-2014E-PDF |
|---|
| 110 | 2 |aPublic Health Agency of Canada. |
|---|
| 245 | 10|aSupplementary statement concerning the laboratory diagnosis of Lymphgranuloma Venereum (LGV) : |h[electronic resource]|bCanadian guidelines on sexually transmitted infections |
|---|
| 260 | |aOttawa - Ontario : |bPublic Health Agency of Canada |cOctober 2014. |
|---|
| 300 | |a2p. |
|---|
| 590 | |a15-05|b2015-01-30 |
|---|
| 690 | 07|aSexually transmitted diseases|2gcpds |
|---|
| 775 | 08|tDéclaration supplémentaire concernant la diagnostic en laboratoire de la Lymphogranulomatose Vénérienne (LGV) : |w(CaOODSP)9.643944 |
|---|
| 794 | |tCanadian guidelines on sexually transmitted infections |w(CaOODSP)9.848935 |
|---|
| 856 | 40|ahttp://publications.gc.ca|qPDF|s140 KB|uhttps://publications.gc.ca/collections/collection_2015/aspc-phac/HP40-1-10-1-2014-eng.pdf |
|---|